Minsheng Group Shaoxing Pharmaceutical Co., Ltd.
⚠️ Moderate Risk
FEI: 3004986788 • Shaoxing, Zhejiang • CHINA
FEI Number
3004986788
Location
Shaoxing, Zhejiang
Country
CHINAAddress
No. 315 Tanggong Road, Paojiang Industrial Zone, , Shaoxing, Zhejiang, China
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
DIRSEXMPT
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NEW VET DR
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 1/19/2023 | 60ZOR32PYRANTEL PAMOATE (ANTIPARASITIC) | 2280DIRSEXMPT | Division of Northeast Imports (DNEI) |
| 10/19/2020 | 60ZCT32PYRANTEL PAMOATE (ANTIPARASITIC) | 3280FRNMFGREG | Division of Southeast Imports (DSEI) |
| 2/13/2013 | 56YJS99ANTIBIOTIC N.E.C. | 72NEW VET DR | New Orleans District Office (NOL-DO) |
| 8/8/2011 | 56YJS99ANTIBIOTIC N.E.C. | Southwest Import District Office (SWI-DO) | |
| 3/30/2011 | 60WAS31PYRANTEL PAMOATE (ANTHELMINTIC) | 118NOT LISTED | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Minsheng Group Shaoxing Pharmaceutical Co., Ltd.'s FDA import refusal history?
Minsheng Group Shaoxing Pharmaceutical Co., Ltd. (FEI: 3004986788) has 5 FDA import refusal record(s) in our database, spanning from 3/30/2011 to 1/19/2023.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Minsheng Group Shaoxing Pharmaceutical Co., Ltd.'s FEI number is 3004986788.
What types of violations has Minsheng Group Shaoxing Pharmaceutical Co., Ltd. received?
Minsheng Group Shaoxing Pharmaceutical Co., Ltd. has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Minsheng Group Shaoxing Pharmaceutical Co., Ltd. come from?
All FDA import refusal data for Minsheng Group Shaoxing Pharmaceutical Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.